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LC–MSIn the present study we determine the contents of isoﬂavones and soyasaponins in seven soy-based
infant formulas available in the Brazilian market to estimate the intake of these bioactive compounds
by infants. The mean contents of isoﬂavones and soyasaponins were 65.9 mg/kg and 55.0 mg/100 g,
respectively. b-Glycosylated isoﬂavones and soyasaponin B-I were the most abundant components in
the analysed samples. The mean estimated intake of isoﬂavones by infants fed soy-based formulas was
0.8 mg/day/kg of body weight, which is twice that of Japanese adults. For soyasaponins, the mean
estimated intake was 9.2 mg/day/kg of body weight, which is up to 6 times higher than the daily intake
of saponins from beans by vegetarians. Considering the estimated intake of these bioactive compounds
from soy-based formulas and the paucity of data regarding their bioavailability, the potential biological
effects of isoﬂavones and soyasaponins in infants should not be overlooked and merits further
investigation.
 2013 Elsevier Ltd. All rights reserved.1. Introduction lar diseases and osteoporosis (Adlercreutz et al., 1991; Ganry,Infant formulas are manufactured liquid or powder food prod-
ucts used to satisfy the nutritional needs of the infant if breastfeed-
ing is impaired. When the infant presents conditions, such as
galactosemia, lactose intolerance and Ig-E mediated cow milk
allergy, or when the parents follow a vegetarian lifestyle,
soy-based formulas are prescribed (Bhatia & Greer, 2008). In the
USA, it is estimated that approximately 20% of infants fed with for-
mulas use those that are soy-based (Bhatia & Greer, 2008). These
products contain from 14% to 16% of soy protein isolate, together
with other ingredients, such as corn syrup, vegetable oils, sucrose,
vitamins and minerals (Bhatia & Greer, 2008; Genovese & Lajolo,
2002).
In the last decades, the implications of the consumption of soy-
based foods on health have been extensively studied (Adlercreutz
et al., 1991; Ganry, 2002; Reynolds et al., 2006). The interest in soy-
beans and soy-based foods is due to geographical epidemiology
indicating that the high consumption of soy-based foods in Asian
populations was associated with a reduced prevalence of various
chronic diseases, such as breast and prostate cancers, cardiovascu-2002; Reynolds et al., 2006). These beneﬁcial effects are related
to the bioactive compounds naturally present in soybeans, mainly
isoﬂavones and soyasaponins (Genovese & Lajolo, 2002). Since iso-
ﬂavones have shown anti-rotavirus activity at the concentrations
found in soy-based formulas (Andres, Donovan, Kuhlenschmidt, &
Kuhlenschmidt, 2007), infants fed these formulas might be pro-
tected from viral infection and related acute gastroenteritis.
Although several studies measured isoﬂavones in infant formu-
las (Garrett, Lee, Friar, & Morgan, 1999; Genovese & Lajolo, 2002;
Irvine, Shand, Fitzpatrick, & Alexander, 1998; Knight, Eden, Huang,
&Waring, 1998; Kuo & Ding, 2004; Murphy, Song, Buseman, & Bar-
ua, 1997; Setchell, Zimmer-Nechemias, Cai, & Heubi, 1997), the
only study investigating the contents of both isoﬂavones and
soyasaponins in soy-based infant formulas was conducted in sam-
ples acquired in the US market (Murphy, Hu, Barua, & Hauck, 2008;
Murphy et al., 1997). For soy infant formulas sold in the Brazilian
market, only data regarding isoﬂavones contents are available
(Genovese & Lajolo, 2002). Since these studies have shown that
soy-based infant formulas are very rich in both classes of bioactive
compounds, some concerns related to their potential biological ef-
fects on infants have been raised (Kang, Badger, Ronis, & Wu, 2010;
Murphy et al., 1997). Even though soyasaponins are generally con-
sidered to have low bioavailability (Hu, Reddy, Hendrich, & Mur-
phy, 2004), there is a need for a more comprehensive description
of isoﬂavones and soyasaponins composition of infant formulas.
Considering the paucity of data on the composition of bioactive
compounds in soy-based infant formulas, especially soyasaponins,
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and soyasaponins in soy-based infant formulas available in the
Brazilian market to estimate the intake of these bioactive com-
pounds by infants.2. Materials and methods
2.1. Standards and chemicals
Daidzin, glicitin, genistin, daidzein, glicitein, genistein, soyas-
apogenol B, soyasaponin B-I, soyasaponin B-II and soyasaponin B-
III standards were purchased from Apin Chemicals Limited
(Abingdon, UK). All solvents were HPLC grade from Tedia (Fairﬁeld,
OH, USA). HPLC grade water was used throughout the experiments
(Milli-Q system, Millipore, Bedford, MA, USA).
2.2. Samples
For the development and validation of the analytical method for
the simultaneous analysis of isoﬂavones and soyasaponins in soy-
based foods, a sample of soy ﬁbre (Yoki) was acquired in a local
supermarket in Rio de Janeiro, Brazil. The seven soy-based infant
formula samples available in the Brazilian market were purchased
in drugstores located in Rio de Janeiro and São Paulo: AlergoMed
(comidaMed, Germany), Nan Soy (Nestlé Infant Nutrition, USA),
Nursoy (Wyeth Nutrition, Ireland), Aptamil 1 and Aptamil 2 (Da-
none Nutrition Baby, Argentina) and Isomil 1 and Isomil 2 (Ab-
bott Laboratories, Netherlands). Three lots of each brand were
obtained and pooled for further analyses.
2.3. Analysis of protein content
The protein content of the soy-based infant formulas was deter-
mined in duplicate using Kjeldahl method for quantiﬁcation of total
organic nitrogen using the conversion factor of 6.25 (AOAC, 2000).
2.4. Analysis of isoﬂavones and soyasaponins by HPLC-DAD–MS
2.4.1. In-house validation
Linearity was evaluated using triplicates of six-points standard
calibration curves with concentrations ranging between 0.1 to
5.0 lg/ml and 0.5 to 20.0 lg/ml for isoﬂavones and soyasaponins,
respectively. In-house accuracy was assessed by a single-level
recovery experiment. This test was performed in triplicate by ana-
lysing non-spiked and spiked (500 lg of soyasaponin B-I, 200 lg of
genistin and 100 lg of genistein in 0.1 g of soy ﬁbre) samples. The
recovery for each analyte was calculated from the content found
in the fortiﬁed sample in relation to the expected amount, subtract-
ing the non-spiked sample content. Precision (repeatability) was
determined for each analyte as the coefﬁcient of variation from
the three replicates analysed in the recovery experiment. For iso-
ﬂavones, which were quantiﬁed using the diode array detector
(DAD), the limits of detection (LOD) and of quantiﬁcation (LOQ)
were calculated using the following equations: LOD = 3.3 (r/S);
LOQ = 10 (r/S), where r is the standard deviation of the response
of a blank (calculated from the linear coefﬁcient of three calibration
curves) and S is the mean angular coefﬁcient of three calibration
curves. For soyasaponins, which were quantiﬁed using the mass
spectrometer (MS), LOD and LOQ were calculated as the concentra-
tions equivalent to three and ten times the signal-to-noise ratio (S/
N), respectively, of the lowest concentration calibration curve point.
S/N ratios were calculated by LCMSolutions software, using a built-
in tool. The employment of S/N ratio is preferable in comparison to
calibration curves parameters for LOD and LOQ calculations, as the
latter approach tends to underestimate these values.2.4.2. Sample preparation
Samples were extracted in triplicate according to a modiﬁcation
of the methods of Genovese and Lajolo (2002), Fang, Yu, and Bad-
ger (2004) and Rostagno, Palma, and Barroso (2005). Brieﬂy, 0.1 g
of sample and 4 ml of aqueous methanol 80% was extracted in an
Ultra-Turrax extractor (IKA, T18 Basic) at 22,000 rpm for one
min. The obtained extract was centrifuged for 10 min at
3000 rpm, the supernatant collected and the residue re-extracted
twice following the same procedure. Next, supernatants were com-
bined and placed in an ultrasound bath for 15 min. The organic sol-
vent was removed with the aid of a rota-evaporator at 170 rpm
(Büchi, 131 EL, Switzerland). The concentrated extract was intro-
duced into a Strata-X solid phase extraction (SPE) cartridge (3 ml,
200 mg, Phenomenex, CA, USA), previously conditioned with
10 ml of methanol and 10 ml of water. The impurities contained
in the extract were eluted with 10 ml of water and the cartridge
was vacuum-dried for 15 min. The analytes were eluted with5 ml
of methanol and the ﬁnal extract was properly diluted with water
prior to HPLC-DAD–MS analysis.
2.4.3. Chromatographic conditions
The LC system (Shimadzu, Kyoto, Japan) comprised a LC-
10ADvp quaternary pump, a CTO-10ASvp column oven, an 8125
manual injector (Rheodyne) with a 20 lL loop and a SPD-
M10Avp DAD. This LC system was coupled to a LC–MS 2010 MS
(Shimadzu, Kyoto, Japan) equipped with an electrospray ion
source. Chromatographic separations were achieved using a
Kromasil C18 column (150  2.1 mm, 5 lm, 100 Å, AkzoNobel,
Bohus, Sweden) maintained at a constant temperature of 40 C.
The LC two-phase mobile system consisted of a gradient of water
(eluent A) and acetonitrile (eluent B), both added with 0.3% formic
acid, with a ﬂow rate of 0.3 ml/min. Prior to injection, the column
was equilibrated with 15% B. After injection of sample, this propor-
tion was modiﬁed to 23% B in 1 min, kept constant until 23 min
and increased to 50% B until the end of the 35 min run. Between
injections, 20 min intervals were used to re-equilibrate the column
with 15% B.
Isoﬂavones were monitored by DAD between 190 and 370 nm
and soyasaponins were monitored by MS using positive ionisation,
with a nebuliser gas (N2) ﬂow of 3.0 L/min, operated in the single
ion monitoring (SIM) mode to detect pseudomolecular ions. Iden-
tiﬁcation of compounds was performed by comparison with reten-
tion time and molecular weight of the respective standard.
Malonylglycosilated and acetylglycosilated isoﬂavones, for which
commercial standards were unavailable, were identiﬁed by their
pseudomolecular ions in the MS.
Quantiﬁcation was performed by external standardisation. Iso-
ﬂavones were quantiﬁed by their DAD peak areas (250 nm). The
contents of malonylglycosilated and acetylglycosilated isoﬂavones
were determined from the calibration curve of the corresponding
b-glycosylated isoﬂavone, correcting for differences in molecular
weight. Soyasaponins (B-I, B-II and B-III) and soyasapogenol were
quantiﬁed by their MS fragment ions,m/z 423 andm/z 223, respec-
tively. Although soyasaponins B-II and B-III isolated standards
were available, these compounds were quantiﬁed together, as it
was not possible to chromatographically separate these com-
pounds. Data were acquired by LCMSsolution software (Shimadzu
Corp., version 2.00, 2000) for the mass spectrometer. Recovery val-
ues were taken into consideration for calculating the contents of
these compounds in the samples.
2.5. Estimation of daily intake of isoﬂavones and soyasaponins
The daily intake of soy isoﬂavones and soyasaponins according
to infant’s age, expressed per kilogram of body weight, was
estimated from the total content of these classes of bioactive
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the recommended use according to the manufacturer’s directions
(number of feeding bottles given per day and amount of powder
used to prepare each feeding bottle) and the mean body weight
(50th percentile) of infants of both sexes, according to age (1–
2 weeks: 3.3 kg; 3–4 weeks: 4.3 kg; 2 months: 5.3 kg; 3 months:
6.1 kg; 4 months: 6.7 kg; 5 months: 7.2 kg; 6 months: 7.6 kg)
(WHO, 2006).2.6. Statistical analyses
Data are presented as mean ± standard deviation. The contents
of isoﬂavones and soyasaponins in the analysed soy-based infant
formulas were compared using analysis of variance (one-way
ANOVA), followed by Tukey’s multiple comparison post-test. All
statistical analyses were performed using GraphPad Prism soft-
ware for Windows, version 5.04 (GraphPad Software, San Diego,
CA). Differences were considered signiﬁcant when p < 0.05.3. Results and discussion
3.1. LC–MS method in-house validation for the analyses of isoﬂavones
and soyasaponins
The method showed good linearity (R2 > 0.994) in the concen-
tration range of 0.1–5.0 lg/ml and 1.0–20.0 lg/ml for isoﬂavones
and soyasaponins, respectively (Table 1). Rostagno et al. (2005)
reported also a very good linearity (R2 > 0.9998) in the range
between 0.1 and 50.0 lg/ml for isoﬂavones using HPLC with UV
detection.
In-house accuracy and precision were evaluated in a recovery
test with three analysis replicates of a soy ﬁbre sample spiked with
genistin, genistein and soyasaponin B-I. Recoveries were
98.9 ± 5.4%, 96.3 ± 2.9% and 109.6 ± 5.6%, respectively. Repeatabili-
ties were 5.5%, 3.0% and 5.1% for genistin, genistein and soyasapo-
nin B-I, respectively, considered adequate for all analytes. Rostagno
et al. (2005) reported recoveries between 80% and 100.5% for
genistin and between 57.1% and 100.3% for genistein. Lin and
Wang (2004) reported a recovery of 98.3% for soyasaponin B-I
and intra-day and inter-day precisions of 7.9% and 10.9%, respec-
tively, using light scattering detection.
LOD and LOQ were determined for the chromatographic meth-
od and for the whole procedure employed to analyse soy samples
(Table 2). Chromatographic LOD and LOQ of isoﬂavones ranged
from 4.9 to 49.9 ng/ml and 14.9 to 151.2 ng/ml, respectively. These
LOQ values were 161–21 times lower than those reported by Rost-
agno et al. (2005) using DAD. In the present study, the LOD and
LOQ of isoﬂavones in soy samples ranged from 0.02 to 0.25 mg/
100 g and 0.07 to 0.76 mg/100 g, respectively. LOD and LOQ of
soyasapogenol B in soy samples of the present study wereTable 1
Calibration parameters of the HPLC-DAD–MS method proposed for isoﬂavones and
soyasaponins analysis.
Compound Concentration range (lg/ml) n1 Slope R2
Daidzin 0.1–5.0 3 144,563 0.9995
Glicitin 0.1–5.0 3 137,962 0.9971
Genistin 0.1–5.0 3 151,974 0.9942
Daidzein 0.1–5.0 3 225,637 0.9971
Glicitein 0.1–5.0 3 40,505 0.9964
Genistein 0.1–5.0 3 241,514 0.9976
Soyasapogenol B 1.0–20.0 3 3536 0.9996
Soyasaponin B-I 1.0–20.0 3 1456 0.9984
Soyasaponin B-II + B-III 1.0–20.0 3 2278 0.9946
1 Numbers of calibration curve replicates.1.47 mg/100 g and 4.91 mg/100 g, respectively. LOD and LOQ of
soyasaponin B-I in soy samples were 3.27 mg/100 g and
10.89 mg/100 g, respectively. Such values were half of those re-
ported by Hubert, Berger, and Daydé (2005) using UV detection.
LOD and LOQ of soyasaponins B-II + B-III in soy samples of the
present study were 2.25 mg/100 g and 7.49 mg/100 g, respectively.
Considering all obtained LOD and LOQ values, the method was con-
sidered adequate for the simultaneous analysis of both classes of
compounds in infant formulas.
3.2. Isoﬂavones and soyasaponins contents in soy-based infant
formulas
Isoﬂavones and soyasaponins are bioactive components present
in the protein fraction of soy-based foods (Murphy et al., 2008;
Speroni, Milesi, & Añón, 2010). Therefore, the determination of
protein content in infant formula samples was necessary to inves-
tigate whether possible differences in their isoﬂavones and soyasa-
ponins contents were due to variations in the protein composition
of each isolate used as ingredient or were simply caused by the
amount of soy protein used in each sample formulation. Protein
contents ranged between 14.3% and 16.5%, with a mean content
of 15.6% and showed good agreement with labelling data (mean
relative difference of 8.5%). As samples showed similar protein
contents, it was deemed unnecessary to express the contents of
isoﬂavones and soyasaponins per mass of protein, and therefore re-
sults were expressed per mass of sample.
The contents of isoﬂavones in infant formula samples are
shown in Table 3. Total isoﬂavones ranged between 16.2 and
85.4 mg/kg, with a mean content of 65.9 mg/kg. Total isoﬂavones
were also expressed as their aglycones equivalents (conjugated
isoﬂavones were converted into their corresponding aglycone).
Studies on soybean isoﬂavones usually express the total concentra-
tion of these components as aglycones, since conjugated forms are
hydrolysed to aglycones during intestinal absorption in humans
(Murphy et al., 1997). Total isoﬂavone aglycones ranged between
11.2 and 52.0 mg/kg, with a mean content of 42.5 mg/kg. There is
a wide range of contents of isoﬂavones in soy-based infant formu-
las reported in the literature. Knight et al. (1998) and Kuo and Ding
(2004) reported slightly lower contents of aglycone isoﬂavones in
soy-based infant formulas, ranging from 6.5 to 13 mg/kg, in com-
parison to our ﬁndings. Murphy et al. (1997), Setchell et al.
(1997), Irvine et al. (1998), Garrett et al. (1999) and Genovese
and Lajolo (2002) reported higher contents of aglycone isoﬂavones
in comparison to those of the present study, ranging from 78 to
205 mg/kg.
The distribution of isoﬂavones among b-glycosilated, malonyl-
glycosilated, acetylglycosilated and aglycones in infant formula
samples are shown in Fig. 1A. In general, these results were inTable 2
Isoﬂavones and soyasaponins limits of detection (LOD) and quantiﬁcation (LOQ) of
the proposed analytical method.
Compound LOD
(ng/ml)
LOQ
(ng/ml)
LOD in soy
(mg/100 g)
LOQ in soy
(mg/100 g)
Isoﬂavones
Daidzin 4.9 14.9 0.02 0.07
Glicitin 29.6 89.6 0.15 0.45
Genistin 35.8 108.5 0.18 0.54
Daidzein 7.8 23.5 0.04 0.12
Glicitein 49.9 151.2 0.25 0.76
Genistein 23.9 72.5 0.12 0.36
Soyasaponins
Soyasapogenol B 294.4 981.4 1.47 4.91
B-I 653.6 2178.6 3.27 10.89
B-II + B-III 449.1 1497.0 2.25 7.49
Table 3
Isoﬂavones contents (mg/kg) in soy-based infant formula samples.1
Sample Ge De Gle Gi Di Gly AGi ADi AGly MDi Total
isoﬂavones
Total aglycone
isoﬂavones
AlergoMed 2.1 ± 0.0 1.5 ± 0.2 ND2 7.3 ± 0.1 2.6 ± 0.1 0.5 ± 0.0 1.2 ± 0.0 ND ND 1.1 ± 0.0 16.2 ± 0.1a 11.2 ± 0.1a
Aptamil 1 6.9 ± 0.0 4.7 ± 0.2 0.9 ± 0.0 30.7 ± 1.7 10.1 ± 0.1 1.4 ± 0.0 4.9 ± 0.0 2.7 ± 0.1 ND 15.7 ± 0.2 78.0 ± 1.6c 50.7 ± 1.0d
Aptamil 2 7.8 ± 0.0 5.1 ± 0.2 1.1 ± 0.1 28.9 ± 0.4 9.6 ± 0.1 1.5 ± 0.0 4.3 ± 0.2 1.9 ± 0.1 ND 16.5 ± 0.2 76.7 ± 0.5c 50.4 ± 0.4c,d
Isomil 1 4.2 ± 0.1 3.5 ± 0.2 ND 23.4 ± 0.1 9.1 ± 0.1 0.9 ± 0.1 6.3 ± 0.1 8.8 ± 0.5 9.1 ± 0.5 20.1 ± 0.3 85.4 ± 1.2d 52.0 ± 0.7d
Isomil 2 5.9 ± 0.1 2.2 ± 0.2 0.7 ± 0.1 23.0 ± 0.0 12.3 ± 0.5 1.8 ± 0.0 4.3 ± 0.2 3.0 ± 0.4 3.1 ± 0.4 18.2 ± 0.7 74.4 ± 2.2c 46.6 ± 1.2c
Nan Soy 6.8 ± 0.1 5.5 ± 0.0 ND 30.8 ± 0.8 10.7 ± 0.7 1.7 ± 0.0 8.8 ± 0.3 ND ND 14.0 ± 0.3 78.3 ± 0.1c 51.0 ± 0.1d
Nursoy 7.9 ± 0.5 3.7 ± 0.1 0.8 ± 0.1 16.0 ± 1.2 7.3 ± 0.1 1.4 ± 0.0 2.5 ± 0.2 0.9 ± 0.1 0.9 ± 0.1 11.2 ± 0.6 52.6 ± 1.8b 35.8 ± 1.2b
1 Values expressed as mean ± standard deviation (n = 3); means in the same column with different superscript letters are signiﬁcantly different (ANOVA, Tukey’s post-test;
p < 0.05); Ge = genistein; De = daidzein; Gle = glycitein; Gi = genistin; Di = daidzin; Gly = glycitin; AGi = acetylgenistin; ADi = acetyldaidzin; AGly = acetylglycitin;
MDi = malonyldaidzin.
2 Not detected.
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ese & Lajolo, 2002; Murphy et al., 1997; Setchell et al., 1997). b-
Glycosylated isoﬂavones (genistin, daidzin and glycitin) were the
most abundant, corresponding to a mean of 51.6% of total isoﬂav-
ones, followed by malonylglycosilated isoﬂavones and aglycones
(genistein, daidzein and glycitein), which accounted for 19.4%
and 16.6%, respectively. Acetylglycosilated isoﬂavones were the
least abundant, corresponding to a mean of only 12.4% of total
isoﬂavones. Aptamil 1, Aptamil 2 and Nan Soy presented little var-
iation regarding the distribution of isoﬂavones. Isomil 1 showed a
lower relative content of b-glycosylated (39.1%) and a higher rela-
tive content of acetylglycosilated (28.4%) isoﬂavones in relation to
the three above-mentioned samples. This proﬁle indicated that the
soy protein used to produce Isomil 1 was probably submitted to
milder heating conditions, since b-glycosylated isoﬂavones areA
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Fig. 1. Distribution of isoﬂavones among (A) b-glycosides, malonylglycosides, acetylformed as a consequence of thermal degradation of malonylglycos-
ilated isoﬂavones (Wang & Murphy, 1996). AlergoMed presented
higher relative contents of b-glycosylated (63.8%) and aglycone
(21.9%) isoﬂavones, as well as lower relative contents of malonyl
(6.8%) and acetylglycosilated (7.5%) isoﬂavones. This proﬁle is con-
sistent with soy protein that has been extensively processed, since
aglycones are produced as a consequence of hydrolysis of conju-
gated isoﬂavones Wang & Murphy, 1994 (Wang & Murphy,
1996). In fact, AlergoMed was produced with hydrolysed soy pro-
tein, probably explaining its high relative content of aglycones.
Considering that isoﬂavones are hydrolysed during intestinal
absorption and thus aglycone cores are responsible for isoﬂavones
potential bioactivity (Murphy et al., 1997), we investigated the dis-
tribution in infant formula samples of isoﬂavones containing gen-
istein, daidzein and glycitein cores (Fig. 1B). Isoﬂavones containingomil 1 Isomil 2 Nursoy AlergoMed
Acetylglycoside Aglycone
omil 1 Isomil 2 Nursoy AlergoMed
Daidzein Glycitein
glycosides and aglycones; (B) genistein, daidzein and glycitein aglycones cores.
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those containing a daidzein core, 52.4% and 42.4%, respectively.
Only 5.2% of isoﬂavones contained a glycitein core. In general,
these relative contents were different than those of other studies
(Genovese & Lajolo, 2002; Murphy et al., 1997; Setchell et al.,
1997), which reported higher proportions of isoﬂavones containing
genistein (mean of 61%) and glycitein cores (mean of 9%) and lower
proportion of daidzein core isoﬂavones (mean of 30%). Daidzein
and genistein have been shown to have a weak oestrogenic activity
and are able to bind with a low afﬁnity to oestrogen receptors
(Fehily, 2003). In relation to antioxidant activity, it has been re-
ported that genistein is more effective than daidzein, since the for-
mer contains two hydroxyl groups while the latter contains only
one. Moreover, glycitein shows a reduced antioxidant activity
due to the blocking of hydroxyl through methylation (Rüfer and
Kulling, 2006).
Soyasaponins contents in the analysed infant formula samples
are given in Table 4. The total soyasaponins contents ranged be-
tween 17.9 and 113.5 mg/100 g, with a mean content of 55.0 mg/
100 g (Table 4). The large variation of total soyasaponins contents
observed in our samples is probably a reﬂection of the soy protein
composition used in the formula’s manufacture and agrees with
data from Murphy et al. (2008), which reported a wide range of
71.8–320.7 mg/100 g. Murphy et al. (2008) reported that the total
soyasaponins mean content of six soy-based infant formula sam-
ples acquired in three different locations in the US was 199.4 mg/
100 g, 3.6 times higher than those found in our samples. It should
be noted that these authors analysed soyasaponins B-V, B-ag, B-bg
and B-ba in addition to B-I and B-II, which were evaluated in the
present study, but have not analysed soyasapogenol B, which
was found in three of the samples analysed in the present study.Table 4
Soyasaponins contents (mg/100 mg) in soy-based infant formula samples.1
Sample Soyasaponin
B-I
Soyasaponin
B-II + B-III
Soyasapogenol
B
Totals
soyasaponins
AlergoMed 43.3 ± 0.0 11.9 ± 0.1 ND2 55.3 ± 0.1b
Aptamil 1 13.2 ± 0.5 4.7 ± 0.3 ND 17.9 ± 0.7a
Aptamil 2 42.6 ± 0.3 17.0 ± 0.2 ND 59.6 ± 0.0c
Isomil 1 42.4 ± 0.1 13.2 ± 0.1 ND 55.7 ± 0.0b
Isomil 2 43.6 ± 2.2 14.1 ± 0.2 6.0 ± 0.1 63.8 ± 2.3d
Nan Soy 38.5 ± 0.0 12.1 ± 1.5 62.9 ± 0.4 113.5 ± 0.4e
Nursoy 11.1 ± 1.0 3.7 ± 0.3 4.7 ± 0.4 19.5 ± 0.5a
1 Values expressed as mean ± standard deviation (n = 3); means in the same
column with different superscript letters are signiﬁcantly different (ANOVA,
Tukey’s post-test; p < 0.05).
2 Not detected.
Table 5
Estimated daily intake (mg/day/kg body weight1) of isoﬂavones and soyasaponins by infa
Sample 1–2 weeks 3–4 weeks 2 m
AlergoMed Isoﬂavone 0.3 0.2 0.2
Soyasaponin 16.3 11.6 11.5
Aptamil 1 Isoﬂavone 1.2 1.0 1.0
Soyasaponin 4.2 3.5 3.6
Aptamil 2 Isoﬂavone NP NP NP
Soyasaponin NP NP NP
Isomil 1 Isoﬂavone 1.5 1.1 1.4
Soyasaponin 16.0 12.3 14.9
Isomil 2 Isoﬂavone NP NP NP
Soyasaponin NP NP NP
Nan Soy Isoﬂavone 1.2 1.0 1.1
Soyasaponin 12.1 10.4 10.5
Nursoy Isoﬂavone 0.8 0.9 0.7
Soyasaponin 3.5 3.6 2.9
1 Percentile 50th of body weight (kg) by age (WHO, 2006).
2 Not prescribed for this age.Even if we only consider soyasaponins B-I and B-II, the samples
analysed by Murphy et al. (2008) showed contents 3.6 times higher
(159.9 mg/100 g) than those observed in the present study. The to-
tal soyasaponins contents observed in the present study were sim-
ilar to that reported by Fang et al. (2004) (117.7 mg/100 g), who
analysed a soy protein isolate sample. For such comparison, we
took into consideration that our infant formulas samples contained
a mean of 15.6% of soy protein.
The major soyasaponin present in the infant formulas samples
was soyasaponin B-I, which corresponded to a mean of 65.5% of
total soyasaponins content, with the exception of Nan Soy, in
which soyasapogenol B was the most abundant (55.4%) soyasapo-
nin. Soyasaponins B-II and B-III accounted together for 21.7% of
soyasaponins content. Soyasapogenol B was observed in only three
of the analysed samples (Isomil 2, Nan Soy and Nursoy), with a
wide range of contents among these samples (6.0–62.9 mg/
100 g), and corresponded to a mean of 29.6% of their total soyasa-
ponins contents. These results agree with those reported by
Murphy et al. (2008), who found that the major soyasaponin was
soyasaponin B-I, followed by soyasaponin B-II (54.7% and 23.0%,
on mean, respectively). The remaining group B soyasaponins (V,
ag, bg and ba) corresponded to 22.3% of total soyasaponins
content, which were not analysed in the present study, as
mentioned before.
To properly compare the contents of isoﬂavones and soyasapo-
nins, values must be expressed on a molar basis, since the former
have about half the mean molecular weight than the latter. While
soyasaponins molar contents in soy-based formulas ranged from
16.1 to 65.2 lmol/100 g, isoﬂavones molar contents varied from
4.2 to 19.7 lmol/100 g. Aptamil 1 and Nursoy showed similar
molar contents of isoﬂavones and soyasaponins, while Aptamil 2,
Isomil 1, Isomil 2 and Nan Soy contained approximately 3 times
more soyasaponins than isoﬂavones, on a molar basis. Alergomed
showed a unique proﬁle of bioactive compounds, with soyasapo-
nins present at a molar content 14 times higher than that of iso-
ﬂavones. Murphy et al. (2008) reported that soy protein isolates,
the source of protein used in infant formula’s manufacture,
contained from 2 to 5 times more soyasaponins than isoﬂavones.3.3. Estimation of daily intake of isoﬂavone and soyasaponins by
infants
The estimated daily intake of the isoﬂavones from soy-based
infant formulas ranged from 0.2 to 1.5 mg/day/kg body weight of
the infant, considering all products and ages, with a mean intake
of 0.8 mg/day/kg (Table 5). These values are lower than datants fed with soy-based formulas according to age.
onths 3 months 4 months 5 months 6 months
0.2 0.3 0.2 0.2
11.3 12.4 11.5 10.2
1.1 0.9 0.8 NP2
3.7 3.2 3.0 NP
NP NP NP 0.8
NP NP NP 9.2
1.2 1.2 1.1 1.1
13.0 13.1 12.2 11.6
NP NP NP 1.0
NP NP NP 13.0
1.1 1.0 1.1 1.0
10.9 10.0 10.8 10.3
0.6 0.7 0.6 0.6
2.5 2.9 2.7 2.5
N.D. Fonseca et al. / Food Chemistry 143 (2014) 492–498 497previously published inthe literature, ranging from 1.6 to 8.0 mg/
day/kg (Genovese & Lajolo, 2002; Irvine et al., 1998; Setchell
et al., 1997). This difference is due to the low contents of isoﬂav-
ones in the samples analysed in the present study. The mean esti-
mated intake in the present study was twice the estimated daily
intake of isoﬂavones by the Japanese adult population (0.4 mg/
day/kg) (Nakamura, Tsuji, & Tonogai, 2000).
By measuring the rates of daily excretion of isoﬂavones in the
urine of infants from 2 to 16 weeks and comparing with data from
adults, Irvine et al. (1998) suggested that infants of this age could
digest, absorb and excrete genistein and daidzein from soy-based
formulas as efﬁciently as adults who consumed soy products. On
the other hand, Setchell et al. (2002) suggested that infants youn-
ger than 4 months are probably unable to absorb isoﬂavones, since
they do not have a fully developed intestinal ﬂora and isoﬂavone
absorption is dependent of colonic microorganisms. Considering
the high intake of isoﬂavones by infants fed with soy-based formu-
las, the potential bioactivity of these compounds and the contra-
dictory data regarding their absorption by infants, further studies
are necessary to assure the safety of the use of soy-based infant
formulas.
The estimated daily intake of the soyasaponins from soy-based
infant formulas varied between 2.5 and 16.3 mg/day/kg body
weight of the infant, considering all products and ages, with a
mean intake of 9.2 mg/day/kg (Table 5). There are no data available
in the literature regarding soyasaponins intake from the ingestion
of soybeans. However, Ridout, Wharf, Price, Johnson, and Fenwick
(1988) reported that the mean intake of soyasaponins from the
consumption of beans, lentils and peas was approximately 110
and 214 mg/day in British and Asian vegetarian adults, respec-
tively. It should be noted that soy belongs to the same botanical
family of these legumes and that soyasaponin B-I has been re-
ported in peas (Taylor, Fields, & Sutherland, 2004). The mean in-
take of soyasaponins in the present study would be 5.8 and 3.1
times higher than that of British and Asian vegetarians (1.6 and
3.0 mg/day/kg, respectively) (Ridout et al., 1988), considering an
adult with mean body weight of 70 kg.
Gurﬁnkel and Rao (2003) suggested that the potential biological
effects of soyasaponins on health are dependent of their chemical
structures. However, the bioavailability of soyasaponins in adults
is apparently low, as these compounds showed low uptake by hu-
man intestinal cells, apparently being metabolised to aglycones by
intestinal microorganisms and excreted in faeces (Hu et al., 2004).
The ability of infants to digest and absorb soyasaponins is largely
unknown. Even though the estimated intake of soyasaponins from
infant formulas was higher than that of isoﬂavones, one should not
expect more pronounced biological effects from soyasaponins in
infants, since these compounds are much less bioavailable than
isoﬂavones. However, one might expect that soyasaponins could
exert a biological effect directly in the gut, possibly by modifying
the intestinal microﬂora. It is noteworthy that the establishment
of the intestinal microﬂora in infants occurs during the ﬁrst year
of life (Stark and Lee, 1982), which coincides with the period when
infant formulas are prescribed.4. Conclusions
The high estimated daily intake of isoﬂavones and soyasaponins
from soy-based infant formulas when compared to adult popula-
tions suggest that the potential biological effects of the consump-
tion of these bioactive compounds by infants should not be
overlooked. Moreover, since data regarding the bioavailability of
isoﬂavones and soyasaponins from soy-based infant formulas are
scarce, long-term studies are needed to evaluate the safety of a
high intake of isoﬂavones and soyasaponins. To this date, however,there are no reports in the literature that show harmful effects of
feeding infants with soy-based formulas.Acknowledgements
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